ロード中...
The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathy
OBJECTIVE: To assess whether neuropathy with anti-myelin-associated glycoprotein (MAG) antibody may improve after treatment with ibrutinib, an oral inhibitor of Bruton tyrosine kinase, we prospectively treated with ibrutinib a cohort of 3 patients with anti-MAG neuropathy and Waldenström macroglobul...
保存先:
| 出版年: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7176252/ https://ncbi.nlm.nih.gov/pubmed/32284437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000720 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|